Dr. Wen-kai Weng M.D., PH.D.?
Update this Profile
Dr. Wen-kai Weng M.D., PH.D., Hematologist (Blood Specialist)
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Wen-kai Weng M.D., PH.D.

Hematologist-Oncologist | Hematology & Oncology

5/5(3)
300 Pasteur Dr Bmt, Room H3249, Mc5 Stanford CA, 94305
Rating

5/5

About

Dr. Wen-kai Weng is a hematologist oncologist practicing in Stanford, CA. Dr. Weng specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Education and Training

Chungshan Medical College 1988

Board Certification

Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology

Internal MedicineAmerican Board of Internal MedicineABIM- 2007

Provider Details

MaleEnglish

Fellowships

  • Stanford University School of Medicine,Stanford, Ca, United States   2002

Publications

  • jourl of clinical investigationTargeting CD137 enhances the efficacy of cetuximab.2014
  • SCIENCE TRANSLATIOL MEDICINEMinimal residual disease monitoring with high2013
  • AMERICAN JOURL OF HEMATOLOGYThe histone deacetylase inhibitor, romidepsin2012
  • JOURL OF CLINICAL INVESTIGATIONStimulation of tural killer cells with a CD1372012
  • JOURL OF CLINICAL ONCOLOGYThe IgG Fc Receptor Fc?RIIIa 158 V2010
  • LEUKEMIA & LYMPHOMATumor-specific recombint idiotype immunisation after chemotherapy as initial treatment for2009
  • American Society of Clinical Oncology Educatiol BookImmune-mediated antitumor effects with antibody therapy.2005
  • JOUNRAL OF CLINICAL ONCOLOGYClinical outcome of lymphoma patients after idiotype vaccition is correlated with humoral immune2004
  • JOURL OF CLINICAL ONCOLOGYTwo immunoglobulin G fragment C receptor polymorphisms independently predict response2003
  • JOURL OF IMMUNOLOGYDifferential induction of D-binding activities following CD19 cross1997
  • JOURL OF BIOLOGICAL CHEMISTRYSIGLING THROUGH CD19 ACTIVATES VAV MITOGEN-ACTIVATED PROTEIN1994
  • JOURL OF IMMUNOLOGYFUNCTIOL EFFECT OF IL-7-ENHANCED CD19 EXPRESSION ON HUMAN B-CELL PRECURSORS1993
  • journal of clinical investigationTargeting CD137 enhances the efficacy of cetuximab.2014
  • Biology of blood and marrow transplantationTotal lymphoid irradiation-antithymocyte globulin conditioning2014
  • SCIENCE TRANSLATIONAL MEDICINEMinimal residual disease monitoring with high2013
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONCancer Vaccines and T Cell Therapy2013
  • BLOODProphylactic rituximab after allogeneic transplantation decreases B2012
  • AMERICAN JOURNAL OF HEMATOLOGYThe histone deacetylase inhibitor, romidepsin2012
  • BONE MARROW TRANSPLANTATIONTandem chemo-mobilization followed by high2012
  • JOURNAL OF CLINICAL INVESTIGATIONStimulation of natural killer cells with a CD1372012
  • BLOODTranscriptome sequencing in Sezary syndrome identifies Sezary cell2012
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAdoptive Immunotherapy with Cytokine2011
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONPhase I/II Trial of GN-BVC2010
  • JOURNAL OF CLINICAL ONCOLOGYThe IgG Fc Receptor Fc?RIIIa 158 V2010
  • BLOODTLI and ATG conditioning with low risk of graft-versus2009
  • LEUKEMIA & LYMPHOMAGenetic polymorphism of the inhibitory IgG Fc receptor FcRIIb is not2009
  • LEUKEMIA & LYMPHOMAImmunoglobulin G Fc Receptor Polymorphisms Do Not Correlate with Response to Chemotherapy or2009
  • LEUKEMIA & LYMPHOMATumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for2009
  • CLINICAL CANCER RESEARCHA Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following2008
  • BLOODThe antileukemia activity of a human anti-CD40 antagonist antibody, HCD1222008
  • BLOODHumoral immune response2007
  • American Society of Clinical Oncology Educational BookImmune-mediated antitumor effects with antibody therapy.2005
  • JOUNRAL OF CLINICAL ONCOLOGYClinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune2004
  • JOURNAL OF CLINICAL ONCOLOGYTwo immunoglobulin G fragment C receptor polymorphisms independently predict response2003
  • LEUKEMIA & LYMPHOMAHepatitis C virus (HCV) and lymphomagenesis2003
  • BLOODExpression of complement inhibitors CD46, CD552001
  • JOURNAL OF IMMUNOLOGYDifferential induction of DNA-binding activities following CD19 cross1997
  • JOURNAL OF BIOLOGICAL CHEMISTRYSIGNALING THROUGH CD19 ACTIVATES VAV MITOGEN-ACTIVATED PROTEIN1994
  • JOURNAL OF IMMUNOLOGYFUNCTIONAL EFFECT OF IL-7-ENHANCED CD19 EXPRESSION ON HUMAN B-CELL PRECURSORS1993

Experience & Accolades

  • Assistant Professor of Medicine (Blood and Marrow Transplantation) andthe Stanford University Medical Center

Dr. Wen-kai Weng M.D., PH.D.'s Practice location

Wen'Kai Weng

300 Pasteur Dr Bmt, Room H3249, Mc5 -
Stanford, CA 94305
Get Direction
New patients: 650-723-7689

Dr. Wen-kai Weng M.D., PH.D.'s reviews

(3)
Write Review

Patient Experience with Dr. Weng


5.0

Based on 3 reviews

Dr. Wen-kai Weng M.D., PH.D. has a rating of 5 out of 5 stars based on the reviews from 3 patients. FindaTopDoc has aggregated the experiences from real patients to help give you more insights and information on how to choose the best Hematologist-Oncologist in your area. These reviews do not reflect a providers level of clinical care, but are a compilation of quality indicators such as bedside manner, wait time, staff friendliness, ease of appointment, and knowledge of conditions and treatments.

Recommended Articles

  • Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research

    There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...

  • The Effect of Sunshine on Lymphoma

    Having a lack of enough vitamin D can drastically effect one's ability to fight many cancers, including lymphoma. So, researchers inevitably wondered whether the addition of Vitamin D to preexisting therapies would prolong patients' lives. The Wilmot Cancer Institute received a $3 million grant for...

  • The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma

    The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...

  • How is Multiple Myeloma Diagnosed?

    Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...

  • The Link Between Lymphoma Radiotherapy and Mesothelioma

    One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...

  • Superheroes Unite For Elementary Student Fighting Lymphoma

    Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...

Nearby Providers

Nearest Hospitals

STANFORD HEALTH CAREl

300 PASTEUR DRIVE STANFORD CA 94305

Head east 891 ft
Turn right onto Pasteur Drive 698 ft
You have arrived at your destination, on the right

LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl

725 WELCH ROAD PALO ALTO CA 94304

Head east 891 ft
Turn right onto Pasteur Drive 754 ft
Turn right onto Welch Road 2045 ft
Turn right 348 ft
Turn left 69 ft
You have arrived at your destination, on the left

MENLO PARK SURGICAL HOSPITALl

570 WILLOW ROAD MENLO PARK CA 94025

Head east 891 ft
Turn right onto Pasteur Drive 754 ft
Turn right onto Welch Road 2864 ft
Turn left onto Quarry Road 1048 ft
Turn right onto Arboretum Road 1357 ft
Turn left onto Palm Drive 1622 ft
Continue straight onto University Avenue 851 ft
Continue onto University Avenue 3088 ft
Turn left onto Middlefield Road 2535 ft
Turn right onto Willow Road 3026 ft
Turn right 219 ft
You have arrived at your destination, on the right